tiprankstipranks
Edwards Lifesciences (EW)
NYSE:EW
US Market

Edwards Lifesciences (EW) Income Statement

Compare
1,857 Followers

Edwards Lifesciences Income Statement

Last quarter (Q4 2024), Edwards Lifesciences's total revenue was $1.39B, a decrease of -9.67% from the same quarter last year. In Q4, Edwards Lifesciences's net income was $385.60M. See Edwards Lifesciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 5.44B$ 6.00B$ 5.38B$ 5.23B$ 4.39B
Gross Profit
$ 4.32B$ 4.63B$ 4.30B$ 3.98B$ 3.31B
Operating Expenses
$ 2.94B$ 3.09B$ 2.51B$ 2.40B$ 1.99B
Depreciation and Amortization
$ 155.20M$ 144.90M$ 166.80M$ 163.30M$ 135.40M
EBITDA
$ 1.72B$ 1.77B$ 1.96B$ 1.89B$ 1.07B
Operating Income
$ 1.38B$ 1.53B$ 1.75B$ 1.35B$ 1.63B
Other Income/Expenses
$ 169.40M$ 64.00M$ 18.90M$ 11.70M$ 19.10M
Pretax Income
$ 1.55B$ 1.60B$ 1.77B$ 1.70B$ 916.70M
Net Income
$ 4.17B$ 1.40B$ 1.52B$ 1.50B$ 823.40M
Per Share Metrics
Basic EPS
$ 6.98$ 2.31$ 2.46$ 2.41$ 1.32
Diluted EPS
$ 6.97$ 2.30$ 2.44$ 2.38$ 1.30
Weighted Average Shares Outstanding
597.70M 606.70M 619.00M 623.30M 622.60M
Weighted Average Shares Outstanding (Diluted)
599.30M 609.40M 624.20M 631.20M 631.90M
Currency in USD

Edwards Lifesciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis